{"count": 20, "results": [{"_id": "37841910", "pmid": 37841910, "pmcid": "PMC10568015", "title": "Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis", "journal": "Front Pharmacol", "authors": ["Wang L", "Tian YF", "Deng WQ"], "date": "2023-09-28T00:00:00Z", "doi": "10.3389/fphar.2023.1215307", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1215307", "score": 50274.977, "text_hl": "Effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@acute respiratory distress syndrome@@@ in preclinical studies: a systematic review and meta-analysis", "citations": {"NLM": "Wang L, Tian YF, Deng WQ. Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis Front Pharmacol. 2023;14():1215307. PMID: 37841910", "BibTeX": "@article{37841910, title={Effects of metformin on acute respiratory distress syndrome in preclinical studies: a systematic review and meta-analysis}, author={Wang L and Tian YF and Deng WQ}, journal={Front Pharmacol}, volume={14}, pages={1215307}}"}}, {"_id": "33310152", "pmid": 33310152, "pmcid": "PMC7834182", "title": "Metformin in acute respiratory distress syndrome: An opinion", "journal": "Exp Gerontol", "authors": ["Uddin MA", "Akhter MS", "Kubra KT", "Siejka A", "Barabutis N"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.exger.2020.111197", "meta_date_publication": "2021 Mar", "meta_volume": "145", "meta_issue": "", "meta_pages": "111197", "score": 50272.812, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ in @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@acute respiratory distress syndrome@@@: An opinion", "citations": {"NLM": "Uddin MA, Akhter MS, Kubra KT, Siejka A, Barabutis N. Metformin in acute respiratory distress syndrome: An opinion Exp Gerontol. 2021 Mar;145():111197. PMID: 33310152", "BibTeX": "@article{33310152, title={Metformin in acute respiratory distress syndrome: An opinion}, author={Uddin MA and Akhter MS and Kubra KT and Siejka A and Barabutis N}, journal={Exp Gerontol}, volume={145}, pages={111197}}"}}, {"_id": "33310173", "pmid": 33310173, "pmcid": "PMC7833191", "title": "Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study", "journal": "Diabetes Res Clin Pract", "authors": ["Jiang N", "Chen Z", "Liu L", "Yin X", "Yang H", "Tan X", "Wang J", "Li H", "Tian M", "Lu Z", "Xiong N", "Gong Y"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.diabres.2020.108619", "meta_date_publication": "2021 Mar", "meta_volume": "173", "meta_issue": "", "meta_pages": "108619", "score": 50271.64, "text_hl": "In the subgroup analysis, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use was associated with the lower incidence of @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@ARDS@@@ in females.", "citations": {"NLM": "Jiang N, Chen Z, Liu L, Yin X, Yang H, Tan X, Wang J, Li H, Tian M, Lu Z, Xiong N, Gong Y. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study Diabetes Res Clin Pract. 2021 Mar;173():108619. PMID: 33310173", "BibTeX": "@article{33310173, title={Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study}, author={Jiang N and Chen Z and Liu L and Yin X and Yang H and Tan X and Wang J and Li H and Tian M and Lu Z and Xiong N and Gong Y}, journal={Diabetes Res Clin Pract}, volume={173}, pages={108619}}"}}, {"_id": "32389018", "pmid": 32389018, "title": "Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study.", "journal": "Ann Palliat Med", "authors": ["Oh TK", "Song IA"], "date": "2020-05-01T00:00:00Z", "doi": "10.21037/apm.2020.04.25", "meta_date_publication": "2020 May", "meta_volume": "9", "meta_issue": "3", "meta_pages": "903-911", "score": 50256.11, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ users were defined as those prescribed continuous oral @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for >=30 days before @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@ARDS@@@ diagnosis. ", "citations": {"NLM": "Oh TK, Song IA. Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study. Ann Palliat Med. 2020 May;9(3):903-911. PMID: 32389018", "BibTeX": "@article{32389018, title={Prior metformin therapy and 30-day mortality in patients with acute respiratory distress syndrome: a nationwide cohort study.}, author={Oh TK and Song IA}, journal={Ann Palliat Med}, volume={9}, number={3}, pages={903-911}}"}}, {"_id": "33081905", "pmid": 33081905, "title": "[Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?]", "journal": "Zhonghua Wei Zhong Bing Ji Jiu Yi Xue", "authors": ["Pan Y", "Han R", "He Y"], "date": "2020-09-01T00:00:00Z", "doi": "10.3760/cma.j.cn121430-20200514-00662", "meta_date_publication": "2020 Sep", "meta_volume": "32", "meta_issue": "9", "meta_pages": "1131-1134", "score": 50253.793, "text_hl": "It was speculated that the use of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ for controlling @CHEMICAL_Blood_Glucose @CHEMICAL_MESH:D001786 @@@blood glucose@@@ in severe @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ @SPECIES_9606 @@@patients@@@ with @DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetes@@@ may prevent or inhibit the occurrence of @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@ARDS@@@, thereby reducing the mortality of @DISEASE_COVID_19 @DISEASE_MESH:D000086382 @@@COVID-19@@@ @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Pan Y, Han R, He Y. [Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?] Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Sep;32(9):1131-1134. PMID: 33081905", "BibTeX": "@article{33081905, title={[Metformin: one of the possible options to reduce the mortality of severe coronavirus disease 2019?]}, author={Pan Y and Han R and He Y}, journal={Zhonghua Wei Zhong Bing Ji Jiu Yi Xue}, volume={32}, number={9}, pages={1131-1134}}"}}, {"_id": "33662839", "pmid": 33662839, "pmcid": "PMC7891082", "title": "Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA", "journal": "Diabetes Metab Syndr", "authors": ["Ghany R", "Palacio A", "Dawkins E", "Chen G", "McCarter D", "Forbes E", "Chung B", "Tamariz L"], "date": "2021-03-01T00:00:00Z", "doi": "10.1016/j.dsx.2021.02.022", "meta_date_publication": "2021 Mar-Apr", "meta_volume": "15", "meta_issue": "2", "meta_pages": "513-518", "score": 50252.64, "text_hl": "The RH of @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@ARDS@@@ for @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ users was 0.32; 95% CI 0.22-0.45. ", "citations": {"NLM": "Ghany R, Palacio A, Dawkins E, Chen G, McCarter D, Forbes E, Chung B, Tamariz L. Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA Diabetes Metab Syndr. 2021 Mar-Apr;15(2):513-518. PMID: 33662839", "BibTeX": "@article{33662839, title={Metformin is associated with lower hospitalizations, mortality and severe coronavirus infection among elderly medicare minority patients in 8 states in USA}, author={Ghany R and Palacio A and Dawkins E and Chen G and McCarter D and Forbes E and Chung B and Tamariz L}, journal={Diabetes Metab Syndr}, volume={15}, number={2}, pages={513-518}}"}}, {"_id": "34115964", "pmid": 34115964, "pmcid": "PMC8189765", "title": "Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation", "journal": "Immunity", "authors": ["Xian H", "Liu Y", "Rundberg Nilsson A", "Gatchalian R", "Crother TR", "Tourtellotte WG", "Zhang Y", "Aleman-Muench GR", "Lewis G", "Chen W", "Kang S", "Luevanos M", "Trudler D", "Lipton SA", "Soroosh P", "Teijaro J", "de la Torre JC", "Arditi M", "Karin M", "Sanchez-Lopez E"], "date": "2021-07-13T00:00:00Z", "doi": "10.1016/j.immuni.2021.05.004", "meta_date_publication": "2021 Jul 13", "meta_volume": "54", "meta_issue": "7", "meta_pages": "1463-1477.e11", "score": 50250.477, "text_hl": "...@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ inhibits @CHEMICAL_Lipopolysaccharides @CHEMICAL_MESH:D008070 @@@LPS@@@-induced @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@ARDS@@@", "citations": {"NLM": "Xian H, Liu Y, Rundberg Nilsson A, Gatchalian R, Crother TR, Tourtellotte WG, Zhang Y, Aleman-Muench GR, Lewis G, Chen W, Kang S, Luevanos M, Trudler D, Lipton SA, Soroosh P, Teijaro J, de la Torre JC, Arditi M, Karin M, Sanchez-Lopez E. Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation Immunity. 2021 Jul 13;54(7):1463-1477.e11. PMID: 34115964", "BibTeX": "@article{34115964, title={Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation}, author={Xian H and Liu Y and Rundberg Nilsson A and Gatchalian R and Crother TR and Tourtellotte WG and Zhang Y and Aleman-Muench GR and Lewis G and Chen W and Kang S and Luevanos M and Trudler D and Lipton SA and Soroosh P and Teijaro J and de la Torre JC and Arditi M and Karin M and Sanchez-Lopez E}, journal={Immunity}, volume={54}, number={7}, pages={1463-1477.e11}}"}}, {"_id": "35834091", "pmid": 35834091, "title": "Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials.", "journal": "Int J Clin Pharm", "authors": ["Li F", "Liu L", "Hu Y", "Marx CM", "Liu W"], "date": "2022-10-01T00:00:00Z", "doi": "10.1007/s11096-022-01438-z", "meta_date_publication": "2022 Oct", "meta_volume": "44", "meta_issue": "5", "meta_pages": "1102-1113", "score": 50249.355, "text_hl": "In the main analysis, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ had lower risk of @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@respiratory distress syndrome@@@ (@<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@RDS@@@, OR, 0.28; 95% CI 0.16-0.51; P < 0.0001), @DISEASE_Premature_Birth @DISEASE_MESH:D047928 @@@premature birth@@@ (OR, 0.42; 95% CI 0.21-0.85, P = 0.02), and @DISEASE_Hypoglycemia @DISEASE_MESH:D007003 @@@neonatal hypoglycemia@@@ (OR, 0.34; 95% CI 0.24-0.48; P < 0.00001) compared to @GENE_INS @GENE_3630 @@@insulin@@@. ", "citations": {"NLM": "Li F, Liu L, Hu Y, Marx CM, Liu W. Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials. Int J Clin Pharm. 2022 Oct;44(5):1102-1113. PMID: 35834091", "BibTeX": "@article{35834091, title={Efficacy and safety of metformin compared to insulin in gestational diabetes: a systemic review and meta-analysis of Chinese randomized controlled trials.}, author={Li F and Liu L and Hu Y and Marx CM and Liu W}, journal={Int J Clin Pharm}, volume={44}, number={5}, pages={1102-1113}}"}}, {"_id": "36131291", "pmid": 36131291, "pmcid": "PMC9494837", "title": "A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol", "journal": "Trials", "authors": ["Dunne F", "Newman C", "Devane D", "Smyth A", "Alvarez-Iglesias A", "Gillespie P", "Browne M", "O'Donnell M"], "date": "2022-09-21T00:00:00Z", "doi": "10.1186/s13063-022-06694-y", "meta_date_publication": "2022 Sep 21", "meta_volume": "23", "meta_issue": "1", "meta_pages": "795", "score": 50248.504, "text_hl": "Non-adherence rate of 8% in the @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group", "citations": {"NLM": "Dunne F, Newman C, Devane D, Smyth A, Alvarez-Iglesias A, Gillespie P, Browne M, O'Donnell M. A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol Trials. 2022 Sep 21;23(1):795. PMID: 36131291", "BibTeX": "@article{36131291, title={A randomised placebo-controlled trial of the effectiveness of early metformin in addition to usual care in the reduction of gestational diabetes mellitus effects (EMERGE): study protocol}, author={Dunne F and Newman C and Devane D and Smyth A and Alvarez-Iglesias A and Gillespie P and Browne M and O'Donnell M}, journal={Trials}, volume={23}, number={1}, pages={795}}"}}, {"_id": "33346525", "pmid": 33346525, "title": "Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.", "journal": "J Drugs Dermatol", "authors": ["Moussa C", "Wadowski L", "Price H", "Mirea L", "O'Haver J"], "date": "2020-12-01T00:00:00Z", "doi": "10.36849/JDD.2020.5447", "meta_date_publication": "2020 Dec 1", "meta_volume": "19", "meta_issue": "12", "meta_pages": "1231-1234", "score": 50247.637, "text_hl": "Two @SPECIES_9606 @@@patients@@@ discontinued @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ therapy due to side effects, including @<m>DISEASE_Respiratory_Distress_Syndrome</m> @DISEASE_MESH:D012128 @@@gastrointestinal distress@@@ and mood changes; the third @SPECIES_9606 @@@patient@@@ discontinued due to lack of improvement. ", "citations": {"NLM": "Moussa C, Wadowski L, Price H, Mirea L, O'Haver J. Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa. J Drugs Dermatol. 2020 Dec 1;19(12):1231-1234. PMID: 33346525", "BibTeX": "@article{33346525, title={Metformin as Adjunctive Therapy for Pediatric Patients With Hidradenitis Suppurativa.}, author={Moussa C and Wadowski L and Price H and Mirea L and O'Haver J}, journal={J Drugs Dermatol}, volume={19}, number={12}, pages={1231-1234}}"}}]}